ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,283Medicare Part D Prescriptions Filled, Including Refills

Rank: 1858 out of 6645

$256K Total Retail Price of All Prescriptions

Rank: 3090 out of 6645

329 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

13% of this provider’s 329 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

1% of this provider’s 6,070 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 268 256 1 1
LISINOPRIL 239 237 2 3
METFORMIN HCL 238 238 3 7
LEVOTHYROXINE SODIUM 221 211 4 4
ALENDRONATE SODIUM 193 193 5 14
AMLODIPINE BESYLATE 191 187 6 2
LOVASTATIN 181 181 7 15
OMEPRAZOLE 160 160 8 6
ATENOLOL 155 154 9 8
ENALAPRIL MALEATE 151 136 10 75
HYDROCODONE-ACETAMINOPHEN 145 125 S3 11 5
HYDROCHLOROTHIAZIDE 144 144 12 9
FINASTERIDE 118 118 13 73
TERAZOSIN HCL 116 116 14 48
ZOLPIDEM TARTRATE 108 104 15 17
GLIMEPIRIDE 106 99 16 47
METOPROLOL TARTRATE 104 102 17 13
GABAPENTIN 101 92 18 18
GLIPIZIDE 81 81 19 23
NAMENDA 76 64 20 41
LISINOPRIL-HYDROCHLOROTHIAZIDE 75 75 21 37
DONEPEZIL HCL 68 68 22 27
CARVEDILOL 66 66 23 25
FUROSEMIDE 64 64 24 11
ATORVASTATIN CALCIUM 62 62 25 10
PRAVASTATIN SODIUM 61 61 26 20
BENAZEPRIL HCL 60 60 27 21
TRAMADOL HCL 57 53 28 30
DIOVAN 51 51 29 19
INSULIN SYRINGE 50 41 30 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 11, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.